VTRS

#670
Viatris Inc. Common Stock
13.9100 USD
+0.58%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
13.9100
13.9100
Intervallo Annuale
9.9200
16.4700
Variazione giornaliera
+0.58%
Variazione Mensile
+2.05%
Variazione di 6 mesi
+34.40%
Variazione Annuale
+34.40%
Chiusura Precedente
13.8300
Apertura
13.9100
Bid
Ask
Minimo
13.9100
High
13.9100
Volume
262
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 16.0159 B
  • Employee 30 K
  • Founded 2020
  • CEO Scott A. Smith
  • Website www.viatris.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y4RQNH4
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.15
Rapporto prezzo/fatturato
—
Dividendi per azione
0.48
Rendimento da dividendi %
3.86

Viatris Inc

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue.

Notizie